Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 69 (TMEM69) is a protein encoded by the human TMEM69 gene on chromosome 1p34.1 and belongs to the DUF3429 family of proteins of unknown function[2][3][5]. The protein consists of 247 amino acids and contains five conserved transmembrane domains, with several predicted post-translational modification sites but no confirmed catalytic or receptor activity[2]. The precise biological function remains uncharacterized; it has been suggested (based primarily on studies in Xenopus) to serve as a scaffolding molecule in G protein–coupled receptor complexes, but this remains speculative for humans[2]. TMEM69 is expressed at low levels throughout the human body, with relatively higher levels in certain neuroendocrine tissues including the liver, amygdala, hippocampus, and hypothalamus[2]. There are no well-established disease associations, known drug interactions, or uses as a therapeutic target or biomarker to date[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 69 (TMEM69).